<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10018">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02031705</url>
  </required_header>
  <id_info>
    <org_study_id>CTI</org_study_id>
    <nct_id>NCT02031705</nct_id>
  </id_info>
  <brief_title>Effect of Cavotricuspid Isthmus Ablation in Patients Without History of Typical Flutter During Ablation</brief_title>
  <official_title>Effect of Cavotricuspid Isthmus Ablation in Patients Without History of Typical Flutter During Ablation for Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul St. Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been demonstrated that successful cavotricuspid isthmus ablation may be effective in
      preventing paroxysmal atrial fibrillation. However, the effectiveness of only isthmus
      ablation on atrial fibrillation itself is unclear.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Researchers hypothesized that an organized activation pattern around the tricuspid annulus
      during atrial fibrillation indicated a mother reentrant circuit that could be terminated by
      a cavocaval isthmus ablation, thus preventing atrial fibrillation. The objectives of the
      present study were to evaluate the effectiveness of isthmus ablation in preventing atrial
      fibrillation and to identify predictors of its success.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Freedom of AF and Af</measure>
    <time_frame>1 year after catheter ablation</time_frame>
    <safety_issue>No</safety_issue>
    <description>1 month, 3 months and 12months after ablation follow up visit and Check the recurrence of atrial fibrillation through EKG,Holter, event recording</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>cavotricuspid isthmus ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Isthmus ablation was performed in paroxysmal atrial fibrillation patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group was performed no additional cavotricuspid isthmus ablation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cavotricuspid isthmus ablation</intervention_name>
    <description>Isthmus ablation was performed in paroxysmal atrial fibrillation patients.</description>
    <arm_group_label>cavotricuspid isthmus ablation</arm_group_label>
    <other_name>cavotricuspid isthmus ablation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>control group</intervention_name>
    <description>Control group was performed no additional cavotricuspid isthmus ablation.</description>
    <arm_group_label>control group</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled ablation for paroxysmal atrial fibrillation

        Exclusion Criteria:

          -  Typical atrial flutter

          -  History of artificial tricuspid valve surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SungHwan Kim, MD</last_name>
    <role>Study Director</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SungHwan Kim, MD</last_name>
    <phone>82-2-2258-1141</phone>
    <email>sunghwan@catholic.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul st. mary's hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SungHwan Kim, MD</last_name>
      <phone>82-2-2258-1141</phone>
      <email>sunghwan@catholic.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 8, 2014</lastchanged_date>
  <firstreceived_date>September 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Yong Seog Oh</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Fibrillation</keyword>
  <keyword>Catheter ablation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
